Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes

Histochemical Journal

Volumn 34, Issue 1-2, 2002, Pages 1-12

  Reddy, S ^a,b   Ginn, S ^b   Ross, J M ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; FAS ANTIGEN; FAS LIGAND; GLUCAGON; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE; PERFORIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CELL DESTRUCTION; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MACROPHAGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET BETA CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, CD95; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, TYPE 1; FAS LIGAND PROTEIN; FEMALE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; ISLETS OF LANGERHANS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICROSCOPY, ULTRAVIOLET; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

ANIMALIA;

EID: 0036380841     PISSN: 00182214     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021321522826     Document Type: Article

References (43)

1. Allison J, Strasser A (1998) Mechanisms of β cell death in diabetes: a minor role for CD95. Proc Natl Acad Sci USA 95: 13818-13822.
2. Allison J, Georgiou HM, Strasser A, Vaux DL (1997) Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 94: 3943-3947.
3. Amrani A, Verdaguer J, Anderson B, Utsugi T, Bou S, Santamaria P (1999) Perforin-independent β-cell destruction by diabetogenic CD8+ T lymphocytes in transgenic nonobese diabetic mice. J Clin Invest 103: 1201-1209.
4. Baran J, Weglarczyk K, Mysiak M, Guzik K, Ernst M, Flad H-D, Pryjma J. (2001) Fas (CD95)-Fas ligand interactions are responsible for monocyte apoptosis occurring as a result of phagocytosis and killing of Staphylococcus aureus. Infection Immunity 69: 1287-1297.
5. Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren P-O, Orrenius S (2001) Role of apoptosis in pancreatic β-cell death in diabetes. Diabetes 50(Suppl 1): S44-S47.
6. Chervonsky AV, Wong FS, Flavell RA, Janeway CA, Matis LA (1997) The role of Fas in autoimmune diabetes. Cell 89: 17-24.
7. Eizirik DL, Darville MI (2001) β-Cell apoptosis and defense mechanisms: lessons from Type 1 diabetes. Diabetes 50(Suppl 1): S64-S69.
8. French LE, Tschopp J. (1996) Constitutive Fas ligand expression in several non-lymphoid tissues: implications for immune protection and cell turnover. Behring Inst Mitt 97: 156-160.
9. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Popoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275: 960-963.
10. Hanke J (2000) Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the developing and adult rat endocrine pancreas. Anatomy and Embryology 202: 303-312.
11. Ingelsson E, Saldeen J, Welsh N (1998) Islet expression of perforin, Fas/Apo-1 and interleukin-1 converting enzyme (ICE) in non-obese diabetic (NOD) mice. Immunol Lett 63: 125-129.
12. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y (1997) Requirement for Fas for the development of autoimmune diabetes in non-obese diabetic mice. J Exp Med 186: 613-618.
13. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H (1996) Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 14: 207-232.
14. Kagi D, Odermatt B, Seiler P, Zinkernagel RM, Mak TW, Hengartner H (1997) Reduced incidence and delayed onset of diabetes in perforin-deficient non-obese diabetic mice. J Exp Med 186: 989-997.
15. Kayagaki N, Yamaguchi N, Nagao F, Matsuo S, Maeda H, Okumura K, Yagita H (1997) Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci USA 94: 3914-3919.
16. Kikutani H, Makino S (1992) The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51: 285-322.
17. Kim Y-H, Kim S, Kim K-A, Yagita H, Kayagaki N, Kim K-W, Lee M-S (1999) Apoptosis of pancreatic β-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol 29: 455-465.
18. Kim S, Kim KA, Hwang DY, Lee TH, Kayagaki N, Yagita H, Lee MS (2000) Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved. J Immunol 164: 2931-2936.
19. Kreuwel HTC, Morgan DJ, Krahl T, Ko A, Sarvetnick N, Sherman LA (1999) Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. J Immunol 163: 4335-4341.
20. Leithauser F, Dhein J, Mechtersheimer G et al. (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumour necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69: 415-429.
21. Loweth AC, Williams GT, James RFL, Scarpello JHB, Morgan NG (1998) Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1β and Fas ligation. Diabetes 47: 727-732.
22. Lowin B, Hahne M, Mattmann C, Tschopp J (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370: 650-652.
23. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontano A, Kaiser N, Donath MY (2001) Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 50: 1683-1690.
24. Mauricio D, Mandrup-Poulsen T (1998) Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 47: 1537-1543.
25. Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y (1999) Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type 1 diabetes mellitus. Diabetologia 42: 1332-1340.
26. Nagata S (1994) Fas and Fas ligand: a death factor and its receptor. Adv Immunol 57: 129-144.
27. Nagata S, Golstein P (1995) The Fas death factor. Science 267: 1449-1456.
28. Rabinovitch A (1998) An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14: 129-151.
29. Reddy S, Wu, D, Swinney C, Elliott RB (1995) Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. Pancreas 11: 16-25.
30. Reddy S, Yip S, Karanam M, Poole CA, Ross JM (1999) An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese (NOD) mice during disease acceleration with cyclophosphamide. Histochem J 31: 303-314.
31. Reddy S, Karanam M, Krissansen G, Nitschke K, Neve J, Poole CA, Ross JM (2000a) Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-γ in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells. Histochem J 32: 195-206.
32. Reddy S, Karanam M, Poole CA, Ross JM (2000b) Dual-label immunohistochemical study of interleukin-4- and interferon-γ-expressing cells within the pancreas of the NOD mouse during disease acceleration with cyclophosphamide. Autoimmunity 32: 181-192.
33. Reddy S, Karanam M, Robinson E (2001a) Prevention of cyclophosphamide-induced accelerated diabetes in the NOD mouse by nicotinamide or a soy protein-based infant formula. Int J Exp Diabetes Res 1: 299-313.
34. Reddy S, Young M, Ginn S (2001b) Immunoexpression of interleukin-1β in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide. Histochem J 33: 317-327.
35. Richardson BC, Buckmaster T, Keren DF, Johnson KJ (1993) Evidence that macrophages are programmed to die after activating autologous, cloned, antigen-specific, CD4+ T cells. Eur J Immunol 23: 1450-1455.
36. Signore A, Annovazzi A, Procaccini E, Beales PE, Spencer J, Testi R, Ruberti G (1997) CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice. Diabetologia 40: 1476-1479.
37. Stassi G, Todaro M, Richiusa P, Giordano M, Mattina A, Sbriglia MS, Lo Monte A, Buscemi G, Galluzzo A, Giordano C (1995) Expression of apoptosis-inducing CD95 (Fas/Apoo-1) on human β-cells sorted by flow-cytometry and cultured in vitro. Transplantation Proc 27: 3271-3275.
38. Stassi G, De Maria R, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M (1997) Nitric oxide primes pancreatic β-cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186: 1193-1200.
39. Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A (1999) β-cell destruction in NOD mice correlates with Fas (CD95) expression on β-cells and proinflammatory cytokine expression in islets. Diabetes 48: 21-28.
40. Suarez-Pinzon WL, Power RF, Rabinovitch A (2000) Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet cells in non-obese diabetic mice. Diabetologia 43: 1149-1156.
41. Thomas HE, Darwiche R, Corbett JA, Kay TWH (1999) Evidence that β cell death in the nonobese diabetic mouse is Fas independent. J Immunol 163: 1562-1569.
42. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K (1996) Mouse islet cell lysis mediated by IL-1-induced Fas. Diabetologia 39: 1306-1312.
43. Zumsteg U, Frigerio S, Hollander GA (2000) Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine β-cell damage. Diabetes 49: 39-47.